B. Riley Cuts OptimizeRx (NASDAQ:OPRX) Price Target to $13.00

OptimizeRx (NASDAQ:OPRX – Free Report) had its price target decreased by B. Riley from $17.00 to $13.00 in a research report released on Tuesday morning,Benzinga reports. B. Riley currently has a buy rating on the stock. OPRX has been the subject of a number of other research reports. Roth Mkm reiterated a “buy” rating and […]

Leave a Reply

Your email address will not be published.

Previous post Broadridge Financial Solutions, Inc. (NYSE:BR) Given Consensus Recommendation of “Hold” by Brokerages
Next post Stock Traders Purchase High Volume of Call Options on Forte Biosciences (NASDAQ:FBRX)